Fumin Feng

8PUBLICATIONS
3CO-AUTHORS
Medical virologyEpidemiological methodsMedical bacteriologyMicro- and nanosystemsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 27, 2025
Inhibition of YAP can down-regulate NLRP3 inflammasome and improve anti-tuberculosis drug-induced liver injury.

Yifei Long, Xueying Li, Yue Liu

|Dec 23, 2024
Effect of the Deubiquitinating Peptidase 7 (USP7) on Hepatitis B Virus (HBV) Replication and the Antiviral Efficacy of Entecavir (ETV).

Yue Liu, Shengfei Pei, Xue Wang

|Apr 30, 2024
Identification of novel resistance-associated mutations and discrimination within whole-genome sequences of fluoroquinolone-resistant Mycobacterium tuberculosis isolates.

Yingzhi Chong, Xueying Li, Yifei Long

|May 25, 2023
Transcriptomics-based investigation of manganese dioxide nanoparticle toxicity in rats' choroid plexus.

Chun-Yan Meng, Xin-Yi Ma, Ming-Yan Xu

|Jan 15, 2022
Screening differential circular RNA expression profiles reveals the regulatory role of circMARS in anti-tuberculosis drug-induced liver injury.

Biao Li, Qi Ren, Yuhong Li

|Mar 18, 2020
Combined 5-hydroxymethylcytosine content of human leucocyte antigen-B and human leucocyte antigen-DQB1 as novel biomarker for anti-tuberculosis drug-induced liver injury.

Yuhong Li, Qi Ren, Dongxue Wu

Pageof 2

Frequent Collaborators

2 joint publications

Yingzhi Chong

1 joint publications

Biao Li

1 joint publications

Qi Ren